Personal information

Other IDs

SciProfiles: 2579390

Countries

Italy

Activities

Collapse all

Works (8)

Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring

International Journal of Molecular Sciences
2024-09-27 | Journal article
DOI: 10.3390/ijms251910453
Contributors: Eleonora Cecchin; Marco Orleni; Sara Gagno; Marcella Montico; Elena Peruzzi; Rossana Roncato; Lorenzo Gerratana; Serena Corsetti; Fabio Puglisi; Giuseppe Toffoli et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Quantitation of tazemetostat in human plasma using liquid chromatography–tandem mass spectrometry

Biomedical Chromatography
2024-07 | Journal article
DOI: 10.1002/bmc.5903
Contributors: Marco Orleni; Robert A. Parise; Julianne L. Holleran; Jennifer E. Amengual; Ye Feng; Timothy Synold; Jan H. Beumer
Source: check_circle
Crossref

Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure

Biomedicine & Pharmacotherapy
2023-08 | Journal article
DOI: 10.1016/j.biopha.2023.114906
Contributors: Rossana Roncato; Elena Peruzzi; Lorenzo Gerratana; Bianca Posocco; Sofia Nuzzo; Marcella Montico; Marco Orleni; Serena Corsetti; Michele Bartoletti; Sara Gagno et al.
Source: check_circle
Crossref

The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure

DARU Journal of Pharmaceutical Sciences
2023-06-15 | Journal article
DOI: 10.1007/s40199-023-00465-z
Contributors: Sara Gagno; Angela Buonadonna; Chiara Dalle Fratte; Michela Guardascione; Martina Zanchetta; Bianca Posocco; Marco Orleni; Giovanni Canil; Rossana Roncato; Erika Cecchin et al.
Source: check_circle
Crossref

LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring

Pharmaceutics
2023-05-18 | Journal article
DOI: 10.3390/pharmaceutics15051524
Contributors: Giovanni Canil; Marco Orleni; Bianca Posocco; Sara Gagno; Alessia Bignucolo; Marcella Montico; Rossana Roncato; Serena Corsetti; Michele Bartoletti; Giuseppe Toffoli
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis

International Journal of Molecular Sciences
2023-02-07 | Journal article
DOI: 10.3390/ijms24043303
Contributors: Chiara Dalle Fratte; Jerry Polesel; Sara Gagno; Bianca Posocco; Elena De Mattia; Rossana Roncato; Marco Orleni; Fabio Puglisi; Michela Guardascione; Angela Buonadonna et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer

Journal of Chromatography B
2021-11 | Journal article
DOI: 10.1016/j.jchromb.2021.122985
Contributors: Ariana Soledad Poetto; Bianca Posocco; Sara Gagno; Marco Orleni; Martina Zanchetta; Valentina Iacuzzi; Giovanni Canil; Mauro Buzzo; Marcella Montico; Michela Guardascione et al.
Source: check_circle
Crossref

A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring

PLOS ONE
2021-10-26 | Journal article
DOI: 10.1371/journal.pone.0259137
Contributors: Martina Zanchetta; A. M. Abd El-Aty; Valentina Iacuzzi; Bianca Posocco; Giorgia Bortolin; Ariana Soledad Poetto; Marco Orleni; Giovanni Canil; Michela Guardascione; Luisa Foltran et al.
Source: check_circle
Crossref
How many people are using ORCID?